nodes	percent_of_prediction	percent_of_DWPC	metapath
Trabectedin—CYP2C9—cardial valve—dilated cardiomyopathy	0.0369	0.679	CbGeAlD
Trabectedin—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.0103	0.0255	CcSEcCtD
Trabectedin—Alopecia—Spironolactone—dilated cardiomyopathy	0.00873	0.0217	CcSEcCtD
Trabectedin—Musculoskeletal pain—Lisinopril—dilated cardiomyopathy	0.00813	0.0202	CcSEcCtD
Trabectedin—Pulmonary embolism—Lisinopril—dilated cardiomyopathy	0.00803	0.02	CcSEcCtD
Trabectedin—Leukopenia—Spironolactone—dilated cardiomyopathy	0.0077	0.0191	CcSEcCtD
Trabectedin—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.00728	0.0181	CcSEcCtD
Trabectedin—Dehydration—Furosemide—dilated cardiomyopathy	0.00722	0.018	CcSEcCtD
Trabectedin—Pulmonary oedema—Lisinopril—dilated cardiomyopathy	0.00715	0.0178	CcSEcCtD
Trabectedin—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.00707	0.0176	CcSEcCtD
Trabectedin—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00687	0.0171	CcSEcCtD
Trabectedin—Hepatic failure—Lisinopril—dilated cardiomyopathy	0.00649	0.0161	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00606	0.0151	CcSEcCtD
Trabectedin—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.00566	0.0141	CcSEcCtD
Trabectedin—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00559	0.0139	CcSEcCtD
Trabectedin—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00555	0.0138	CcSEcCtD
Trabectedin—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.00546	0.0136	CcSEcCtD
Trabectedin—Dehydration—Lisinopril—dilated cardiomyopathy	0.00542	0.0135	CcSEcCtD
Trabectedin—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00517	0.0129	CcSEcCtD
Trabectedin—SRC—heart—dilated cardiomyopathy	0.00498	0.0918	CbGeAlD
Trabectedin—Angiopathy—Furosemide—dilated cardiomyopathy	0.00488	0.0121	CcSEcCtD
Trabectedin—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.0048	0.0119	CcSEcCtD
Trabectedin—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.00478	0.0119	CcSEcCtD
Trabectedin—Neutropenia—Lisinopril—dilated cardiomyopathy	0.00471	0.0117	CcSEcCtD
Trabectedin—Malnutrition—Furosemide—dilated cardiomyopathy	0.00468	0.0116	CcSEcCtD
Trabectedin—Dizziness—Spironolactone—dilated cardiomyopathy	0.00464	0.0115	CcSEcCtD
Trabectedin—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00458	0.0114	CcSEcCtD
Trabectedin—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00456	0.0113	CcSEcCtD
Trabectedin—Vomiting—Spironolactone—dilated cardiomyopathy	0.00446	0.0111	CcSEcCtD
Trabectedin—Rash—Spironolactone—dilated cardiomyopathy	0.00442	0.011	CcSEcCtD
Trabectedin—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00442	0.011	CcSEcCtD
Trabectedin—Headache—Spironolactone—dilated cardiomyopathy	0.0044	0.0109	CcSEcCtD
Trabectedin—Jaundice—Lisinopril—dilated cardiomyopathy	0.00438	0.0109	CcSEcCtD
Trabectedin—Anaemia—Furosemide—dilated cardiomyopathy	0.00432	0.0107	CcSEcCtD
Trabectedin—SRC—cardiac atrium—dilated cardiomyopathy	0.00426	0.0785	CbGeAlD
Trabectedin—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.00425	0.0106	CcSEcCtD
Trabectedin—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00419	0.0104	CcSEcCtD
Trabectedin—Leukopenia—Furosemide—dilated cardiomyopathy	0.00419	0.0104	CcSEcCtD
Trabectedin—Nausea—Spironolactone—dilated cardiomyopathy	0.00417	0.0104	CcSEcCtD
Trabectedin—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00397	0.00987	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00396	0.00983	CcSEcCtD
Trabectedin—Shock—Furosemide—dilated cardiomyopathy	0.00376	0.00934	CcSEcCtD
Trabectedin—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00374	0.00931	CcSEcCtD
Trabectedin—Flushing—Lisinopril—dilated cardiomyopathy	0.00374	0.0093	CcSEcCtD
Trabectedin—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00374	0.00929	CcSEcCtD
Trabectedin—Skin disorder—Furosemide—dilated cardiomyopathy	0.00371	0.00922	CcSEcCtD
Trabectedin—Angiopathy—Lisinopril—dilated cardiomyopathy	0.00366	0.00909	CcSEcCtD
Trabectedin—Anorexia—Furosemide—dilated cardiomyopathy	0.00364	0.00905	CcSEcCtD
Trabectedin—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.00363	0.00903	CcSEcCtD
Trabectedin—Hypotension—Furosemide—dilated cardiomyopathy	0.00357	0.00887	CcSEcCtD
Trabectedin—Alopecia—Lisinopril—dilated cardiomyopathy	0.00356	0.00886	CcSEcCtD
Trabectedin—Mental disorder—Lisinopril—dilated cardiomyopathy	0.00353	0.00878	CcSEcCtD
Trabectedin—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00351	0.00873	CcSEcCtD
Trabectedin—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00344	0.00854	CcSEcCtD
Trabectedin—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00343	0.00852	CcSEcCtD
Trabectedin—Back pain—Lisinopril—dilated cardiomyopathy	0.0034	0.00844	CcSEcCtD
Trabectedin—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00332	0.00825	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.0033	0.00819	CcSEcCtD
Trabectedin—Fatigue—Furosemide—dilated cardiomyopathy	0.00329	0.00818	CcSEcCtD
Trabectedin—Constipation—Furosemide—dilated cardiomyopathy	0.00326	0.00812	CcSEcCtD
Trabectedin—Anaemia—Lisinopril—dilated cardiomyopathy	0.00324	0.00806	CcSEcCtD
Trabectedin—Syncope—Lisinopril—dilated cardiomyopathy	0.00315	0.00782	CcSEcCtD
Trabectedin—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00314	0.00781	CcSEcCtD
Trabectedin—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00312	0.00776	CcSEcCtD
Trabectedin—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00309	0.00767	CcSEcCtD
Trabectedin—Cough—Lisinopril—dilated cardiomyopathy	0.00306	0.00761	CcSEcCtD
Trabectedin—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00302	0.0075	CcSEcCtD
Trabectedin—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00302	0.0075	CcSEcCtD
Trabectedin—Myalgia—Lisinopril—dilated cardiomyopathy	0.00299	0.00743	CcSEcCtD
Trabectedin—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00299	0.00743	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00297	0.00738	CcSEcCtD
Trabectedin—Oedema—Lisinopril—dilated cardiomyopathy	0.00286	0.00712	CcSEcCtD
Trabectedin—Infection—Lisinopril—dilated cardiomyopathy	0.00285	0.00707	CcSEcCtD
Trabectedin—Shock—Lisinopril—dilated cardiomyopathy	0.00282	0.00701	CcSEcCtD
Trabectedin—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00281	0.00699	CcSEcCtD
Trabectedin—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.0028	0.00697	CcSEcCtD
Trabectedin—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00278	0.00692	CcSEcCtD
Trabectedin—Asthenia—Furosemide—dilated cardiomyopathy	0.00274	0.00681	CcSEcCtD
Trabectedin—Anorexia—Lisinopril—dilated cardiomyopathy	0.00273	0.00679	CcSEcCtD
Trabectedin—Hypotension—Lisinopril—dilated cardiomyopathy	0.00268	0.00665	CcSEcCtD
Trabectedin—PTGS1—myocardium—dilated cardiomyopathy	0.00267	0.0491	CbGeAlD
Trabectedin—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00261	0.00649	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00261	0.00649	CcSEcCtD
Trabectedin—Insomnia—Lisinopril—dilated cardiomyopathy	0.00259	0.00644	CcSEcCtD
Trabectedin—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00257	0.00639	CcSEcCtD
Trabectedin—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00255	0.00635	CcSEcCtD
Trabectedin—Dizziness—Furosemide—dilated cardiomyopathy	0.00252	0.00628	CcSEcCtD
Trabectedin—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00252	0.00627	CcSEcCtD
Trabectedin—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00249	0.00619	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00247	0.00615	CcSEcCtD
Trabectedin—Fatigue—Lisinopril—dilated cardiomyopathy	0.00247	0.00614	CcSEcCtD
Trabectedin—Constipation—Lisinopril—dilated cardiomyopathy	0.00245	0.00609	CcSEcCtD
Trabectedin—Vomiting—Furosemide—dilated cardiomyopathy	0.00243	0.00603	CcSEcCtD
Trabectedin—Rash—Furosemide—dilated cardiomyopathy	0.00241	0.00598	CcSEcCtD
Trabectedin—Dermatitis—Furosemide—dilated cardiomyopathy	0.00241	0.00598	CcSEcCtD
Trabectedin—Headache—Furosemide—dilated cardiomyopathy	0.00239	0.00595	CcSEcCtD
Trabectedin—SRC—Platelet activation, signaling and aggregation—TTN—dilated cardiomyopathy	0.00237	0.00437	CbGpPWpGaD
Trabectedin—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00234	0.00582	CcSEcCtD
Trabectedin—SRC—Developmental Biology—ZIC3—dilated cardiomyopathy	0.00231	0.00425	CbGpPWpGaD
Trabectedin—PTGS1—Overview of nanoparticle effects—TNF—dilated cardiomyopathy	0.00229	0.00421	CbGpPWpGaD
Trabectedin—SRC—Rac1/Pak1/p38/MMP-2 pathway—ITGB1—dilated cardiomyopathy	0.00228	0.0042	CbGpPWpGaD
Trabectedin—Nausea—Furosemide—dilated cardiomyopathy	0.00227	0.00564	CcSEcCtD
Trabectedin—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00226	0.00563	CcSEcCtD
Trabectedin—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00226	0.00563	CcSEcCtD
Trabectedin—SRC—Nongenotropic Androgen signaling—RAF1—dilated cardiomyopathy	0.00225	0.00415	CbGpPWpGaD
Trabectedin—SRC—Kit receptor signaling pathway—RPS6KB1—dilated cardiomyopathy	0.00225	0.00414	CbGpPWpGaD
Trabectedin—CYP2E1—Vitamin A and Carotenoid Metabolism—CD36—dilated cardiomyopathy	0.00218	0.00402	CbGpPWpGaD
Trabectedin—SRC—RANKL/RANK Signaling Pathway—RAC1—dilated cardiomyopathy	0.00215	0.00396	CbGpPWpGaD
Trabectedin—SRC—Integrins in angiogenesis—RPS6KB1—dilated cardiomyopathy	0.00213	0.00393	CbGpPWpGaD
Trabectedin—SRC—Thromboxane A2 receptor signaling—RAC1—dilated cardiomyopathy	0.00212	0.0039	CbGpPWpGaD
Trabectedin—SRC—Syndecan-3-mediated signaling events—EGFR—dilated cardiomyopathy	0.00211	0.00389	CbGpPWpGaD
Trabectedin—SRC—E-cadherin signaling in keratinocytes—EGFR—dilated cardiomyopathy	0.00211	0.00389	CbGpPWpGaD
Trabectedin—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00211	0.00525	CcSEcCtD
Trabectedin—SRC—Signalling to RAS—RAF1—dilated cardiomyopathy	0.00209	0.00385	CbGpPWpGaD
Trabectedin—SRC—Signaling of Hepatocyte Growth Factor Receptor—RAF1—dilated cardiomyopathy	0.00209	0.00385	CbGpPWpGaD
Trabectedin—SRC—VEGFR2 mediated cell proliferation—RAF1—dilated cardiomyopathy	0.00209	0.00385	CbGpPWpGaD
Trabectedin—SRC—Platelet activation, signaling and aggregation—ACTN2—dilated cardiomyopathy	0.00206	0.00379	CbGpPWpGaD
Trabectedin—SRC—TSH signaling pathway—RPS6KB1—dilated cardiomyopathy	0.00206	0.00378	CbGpPWpGaD
Trabectedin—Asthenia—Lisinopril—dilated cardiomyopathy	0.00206	0.00511	CcSEcCtD
Trabectedin—SRC—Class I PI3K signaling events mediated by Akt—RAF1—dilated cardiomyopathy	0.00205	0.00377	CbGpPWpGaD
Trabectedin—CYP2C9—heart—dilated cardiomyopathy	0.00204	0.0375	CbGeAlD
Trabectedin—SRC—Signaling events mediated by focal adhesion kinase—RAC1—dilated cardiomyopathy	0.00198	0.00364	CbGpPWpGaD
Trabectedin—SRC—Focal Adhesion—VCL—dilated cardiomyopathy	0.00198	0.00364	CbGpPWpGaD
Trabectedin—SRC—CDC42 signaling events—RPS6KB1—dilated cardiomyopathy	0.00196	0.00361	CbGpPWpGaD
Trabectedin—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00196	0.00487	CcSEcCtD
Trabectedin—SRC—Endothelins—RAC1—dilated cardiomyopathy	0.00193	0.00355	CbGpPWpGaD
Trabectedin—SRC—Integrins in angiogenesis—RAC1—dilated cardiomyopathy	0.00193	0.00355	CbGpPWpGaD
Trabectedin—SRC—Internalization of ErbB1—RAF1—dilated cardiomyopathy	0.00192	0.00353	CbGpPWpGaD
Trabectedin—SRC—CXCR3-mediated signaling events—RAF1—dilated cardiomyopathy	0.00192	0.00353	CbGpPWpGaD
Trabectedin—SRC—LPA receptor mediated events—RAC1—dilated cardiomyopathy	0.0019	0.0035	CbGpPWpGaD
Trabectedin—Dizziness—Lisinopril—dilated cardiomyopathy	0.00189	0.00471	CcSEcCtD
Trabectedin—SRC—PDGF Pathway—RAF1—dilated cardiomyopathy	0.00188	0.00345	CbGpPWpGaD
Trabectedin—PTGS1—heart—dilated cardiomyopathy	0.00186	0.0343	CbGeAlD
Trabectedin—SRC—AGE/RAGE pathway—RAC1—dilated cardiomyopathy	0.00186	0.00342	CbGpPWpGaD
Trabectedin—SRC—Leptin signaling pathway—RPS6KB1—dilated cardiomyopathy	0.00186	0.00342	CbGpPWpGaD
Trabectedin—SRC—Rac1/Pak1/p38/MMP-2 pathway—RAC1—dilated cardiomyopathy	0.00184	0.00338	CbGpPWpGaD
Trabectedin—Vomiting—Lisinopril—dilated cardiomyopathy	0.00182	0.00453	CcSEcCtD
Trabectedin—SRC—Costimulation by the CD28 family—RAC1—dilated cardiomyopathy	0.00181	0.00334	CbGpPWpGaD
Trabectedin—Rash—Lisinopril—dilated cardiomyopathy	0.00181	0.00449	CcSEcCtD
Trabectedin—Dermatitis—Lisinopril—dilated cardiomyopathy	0.0018	0.00449	CcSEcCtD
Trabectedin—SRC—ErbB2/ErbB3 signaling events—RAF1—dilated cardiomyopathy	0.0018	0.00332	CbGpPWpGaD
Trabectedin—Headache—Lisinopril—dilated cardiomyopathy	0.00179	0.00446	CcSEcCtD
Trabectedin—SRC—CDC42 signaling events—RAC1—dilated cardiomyopathy	0.00177	0.00326	CbGpPWpGaD
Trabectedin—PTGS1—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.00177	0.00326	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—SCN5A—dilated cardiomyopathy	0.00175	0.00322	CbGpPWpGaD
Trabectedin—SRC—Platelet activation, signaling and aggregation—VCL—dilated cardiomyopathy	0.00175	0.00322	CbGpPWpGaD
Trabectedin—SRC—L1CAM interactions—ITGB1—dilated cardiomyopathy	0.00171	0.00315	CbGpPWpGaD
Trabectedin—SRC—Signalling to ERKs—RAF1—dilated cardiomyopathy	0.0017	0.00314	CbGpPWpGaD
Trabectedin—SRC—Interleukin-11 Signaling Pathway—RAF1—dilated cardiomyopathy	0.0017	0.00314	CbGpPWpGaD
Trabectedin—Nausea—Lisinopril—dilated cardiomyopathy	0.0017	0.00423	CcSEcCtD
Trabectedin—PTGS1—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.00169	0.00311	CbGpPWpGaD
Trabectedin—SRC—Nanoparticle-mediated activation of receptor signaling—EGFR—dilated cardiomyopathy	0.00168	0.00309	CbGpPWpGaD
Trabectedin—SRC—Leptin signaling pathway—RAC1—dilated cardiomyopathy	0.00168	0.00309	CbGpPWpGaD
Trabectedin—SRC—Cell surface interactions at the vascular wall—ITGB1—dilated cardiomyopathy	0.00167	0.00307	CbGpPWpGaD
Trabectedin—SRC—Integrin-mediated Cell Adhesion—ITGB1—dilated cardiomyopathy	0.00166	0.00305	CbGpPWpGaD
Trabectedin—SRC—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	0.00164	0.00303	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.00164	0.00303	CbGpPWpGaD
Trabectedin—SRC—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—RAC1—dilated cardiomyopathy	0.00159	0.00293	CbGpPWpGaD
Trabectedin—PTGS1—cardiac atrium—dilated cardiomyopathy	0.00159	0.0293	CbGeAlD
Trabectedin—SRC—Fcgamma receptor (FCGR) dependent phagocytosis—RAC1—dilated cardiomyopathy	0.00158	0.0029	CbGpPWpGaD
Trabectedin—SRC—IL-3 Signaling Pathway—RAF1—dilated cardiomyopathy	0.00156	0.00288	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.00155	0.00284	CbGpPWpGaD
Trabectedin—CYP2C19—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.00153	0.00282	CbGpPWpGaD
Trabectedin—SRC—CXCR4-mediated signaling events—RAC1—dilated cardiomyopathy	0.00153	0.00282	CbGpPWpGaD
Trabectedin—SRC—Androgen receptor signaling pathway—RAC1—dilated cardiomyopathy	0.00146	0.00269	CbGpPWpGaD
Trabectedin—SRC—Arf6 signaling events—EGFR—dilated cardiomyopathy	0.0014	0.00258	CbGpPWpGaD
Trabectedin—SRC—EPH-Ephrin signaling—RAC1—dilated cardiomyopathy	0.0014	0.00258	CbGpPWpGaD
Trabectedin—CYP2C9—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.0014	0.00257	CbGpPWpGaD
Trabectedin—SRC—L1CAM interactions—RAC1—dilated cardiomyopathy	0.00138	0.00253	CbGpPWpGaD
Trabectedin—SRC—Kit receptor signaling pathway—RAF1—dilated cardiomyopathy	0.00135	0.00248	CbGpPWpGaD
Trabectedin—SRC—Cell-Cell communication—ITGB1—dilated cardiomyopathy	0.00134	0.00247	CbGpPWpGaD
Trabectedin—SRC—Integrin-mediated Cell Adhesion—RAC1—dilated cardiomyopathy	0.00133	0.00245	CbGpPWpGaD
Trabectedin—SRC—TGF-beta Signaling Pathway—ITGB1—dilated cardiomyopathy	0.00133	0.00244	CbGpPWpGaD
Trabectedin—SRC—Internalization of ErbB1—EGFR—dilated cardiomyopathy	0.00131	0.00242	CbGpPWpGaD
Trabectedin—SRC—Signaling events mediated by focal adhesion kinase—RAF1—dilated cardiomyopathy	0.00131	0.00241	CbGpPWpGaD
Trabectedin—SRC—ErbB1 downstream signaling—RAC1—dilated cardiomyopathy	0.00128	0.00236	CbGpPWpGaD
Trabectedin—SRC—Endothelins—RAF1—dilated cardiomyopathy	0.00128	0.00235	CbGpPWpGaD
Trabectedin—SRC—VEGFA-VEGFR2 Pathway—RAC1—dilated cardiomyopathy	0.00126	0.00232	CbGpPWpGaD
Trabectedin—SRC—Signaling events mediated by TCPTP—EGFR—dilated cardiomyopathy	0.00126	0.00232	CbGpPWpGaD
Trabectedin—SRC—Oncostatin M Signaling Pathway—RAF1—dilated cardiomyopathy	0.00125	0.00229	CbGpPWpGaD
Trabectedin—SRC—TSH signaling pathway—RAF1—dilated cardiomyopathy	0.00123	0.00227	CbGpPWpGaD
Trabectedin—SRC—AGE/RAGE pathway—RAF1—dilated cardiomyopathy	0.00123	0.00227	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—TTN—dilated cardiomyopathy	0.00122	0.00225	CbGpPWpGaD
Trabectedin—SRC—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—EGFR—dilated cardiomyopathy	0.00121	0.00223	CbGpPWpGaD
Trabectedin—SRC—Signaling events mediated by VEGFR1 and VEGFR2—RAF1—dilated cardiomyopathy	0.0012	0.00221	CbGpPWpGaD
Trabectedin—SRC—NCAM signaling for neurite out-growth—RAF1—dilated cardiomyopathy	0.0012	0.00221	CbGpPWpGaD
Trabectedin—SRC—Signaling by VEGF—RAC1—dilated cardiomyopathy	0.00119	0.00219	CbGpPWpGaD
Trabectedin—SRC—EGF/EGFR Signaling Pathway—GJA1—dilated cardiomyopathy	0.00119	0.00219	CbGpPWpGaD
Trabectedin—SRC—CDC42 signaling events—RAF1—dilated cardiomyopathy	0.00118	0.00216	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—PSEN2—dilated cardiomyopathy	0.00114	0.0021	CbGpPWpGaD
Trabectedin—SRC—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.00113	0.00208	CbGpPWpGaD
Trabectedin—SRC—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	0.00113	0.00208	CbGpPWpGaD
Trabectedin—SRC—PDGFR-beta signaling pathway—RAC1—dilated cardiomyopathy	0.00111	0.00205	CbGpPWpGaD
Trabectedin—SRC—Leptin signaling pathway—RAF1—dilated cardiomyopathy	0.00111	0.00205	CbGpPWpGaD
Trabectedin—SRC—BDNF signaling pathway—RPS6KB1—dilated cardiomyopathy	0.0011	0.00203	CbGpPWpGaD
Trabectedin—SRC—Posttranslational regulation of adherens junction stability and dissassembly—EGFR—dilated cardiomyopathy	0.00109	0.00201	CbGpPWpGaD
Trabectedin—SRC—Cell-Cell communication—RAC1—dilated cardiomyopathy	0.00108	0.00199	CbGpPWpGaD
Trabectedin—SRC—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	0.00107	0.00198	CbGpPWpGaD
Trabectedin—SRC—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.00107	0.00198	CbGpPWpGaD
Trabectedin—SRC—TGF-beta Signaling Pathway—RAC1—dilated cardiomyopathy	0.00107	0.00196	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—ACTN2—dilated cardiomyopathy	0.00106	0.00195	CbGpPWpGaD
Trabectedin—SRC—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—RAF1—dilated cardiomyopathy	0.00106	0.00194	CbGpPWpGaD
Trabectedin—SRC—Membrane Trafficking—GJA1—dilated cardiomyopathy	0.00105	0.00193	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways in Glioblastoma—RAF1—dilated cardiomyopathy	0.00104	0.00191	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—PSEN2—dilated cardiomyopathy	0.00103	0.0019	CbGpPWpGaD
Trabectedin—SRC—Signaling events mediated by PTP1B—EGFR—dilated cardiomyopathy	0.00102	0.00188	CbGpPWpGaD
Trabectedin—SRC—Signaling by SCF-KIT—RAC1—dilated cardiomyopathy	0.00101	0.00186	CbGpPWpGaD
Trabectedin—SRC—EGF/EGFR Signaling Pathway—RPS6KB1—dilated cardiomyopathy	0.001	0.00184	CbGpPWpGaD
Trabectedin—SRC—BDNF signaling pathway—RAC1—dilated cardiomyopathy	0.000995	0.00183	CbGpPWpGaD
Trabectedin—SRC—Focal Adhesion—ITGB1—dilated cardiomyopathy	0.000992	0.00183	CbGpPWpGaD
Trabectedin—SRC—ErbB Signaling Pathway—EGFR—dilated cardiomyopathy	0.000992	0.00183	CbGpPWpGaD
Trabectedin—SRC—Thromboxane A2 receptor signaling—EGFR—dilated cardiomyopathy	0.000963	0.00177	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000948	0.00174	CbGpPWpGaD
Trabectedin—SRC—EGF/EGFR Signaling Pathway—RAC1—dilated cardiomyopathy	0.000906	0.00167	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—VCL—dilated cardiomyopathy	0.000903	0.00166	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000891	0.00164	CbGpPWpGaD
Trabectedin—SRC—Integrin-mediated Cell Adhesion—RAF1—dilated cardiomyopathy	0.000884	0.00163	CbGpPWpGaD
Trabectedin—SRC—LPA receptor mediated events—EGFR—dilated cardiomyopathy	0.000866	0.00159	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000864	0.00159	CbGpPWpGaD
Trabectedin—SRC—ErbB1 downstream signaling—RAF1—dilated cardiomyopathy	0.00085	0.00156	CbGpPWpGaD
Trabectedin—SRC—Senescence and Autophagy in Cancer—RAF1—dilated cardiomyopathy	0.00085	0.00156	CbGpPWpGaD
Trabectedin—SRC—AGE/RAGE pathway—EGFR—dilated cardiomyopathy	0.000845	0.00155	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.00084	0.00155	CbGpPWpGaD
Trabectedin—SRC—VEGFA-VEGFR2 Pathway—RAF1—dilated cardiomyopathy	0.000837	0.00154	CbGpPWpGaD
Trabectedin—SRC—Rac1/Pak1/p38/MMP-2 pathway—EGFR—dilated cardiomyopathy	0.000835	0.00154	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000813	0.0015	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.00081	0.00149	CbGpPWpGaD
Trabectedin—SRC—Focal Adhesion—RAC1—dilated cardiomyopathy	0.000797	0.00147	CbGpPWpGaD
Trabectedin—SRC—Membrane Trafficking—RAC1—dilated cardiomyopathy	0.000797	0.00147	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.000794	0.00146	CbGpPWpGaD
Trabectedin—SRC—Signaling by VEGF—RAF1—dilated cardiomyopathy	0.00079	0.00145	CbGpPWpGaD
Trabectedin—SRC—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	0.00075	0.00138	CbGpPWpGaD
Trabectedin—SRC—PDGFR-beta signaling pathway—RAF1—dilated cardiomyopathy	0.000739	0.00136	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—PSEN2—dilated cardiomyopathy	0.000738	0.00136	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000732	0.00135	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways in Glioblastoma—EGFR—dilated cardiomyopathy	0.00071	0.00131	CbGpPWpGaD
Trabectedin—SRC—TGF-beta Signaling Pathway—RAF1—dilated cardiomyopathy	0.000708	0.0013	CbGpPWpGaD
Trabectedin—SRC—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	0.000707	0.0013	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—TAZ—dilated cardiomyopathy	0.000689	0.00127	CbGpPWpGaD
Trabectedin—PTGS1—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	0.000672	0.00124	CbGpPWpGaD
Trabectedin—SRC—Signaling by SCF-KIT—RAF1—dilated cardiomyopathy	0.000671	0.00124	CbGpPWpGaD
Trabectedin—SRC—Androgen receptor signaling pathway—EGFR—dilated cardiomyopathy	0.000665	0.00122	CbGpPWpGaD
Trabectedin—SRC—BDNF signaling pathway—RAF1—dilated cardiomyopathy	0.00066	0.00121	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—ITGB1—dilated cardiomyopathy	0.000647	0.00119	CbGpPWpGaD
Trabectedin—SRC—L1CAM interactions—EGFR—dilated cardiomyopathy	0.000626	0.00115	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—SDHA—dilated cardiomyopathy	0.000623	0.00115	CbGpPWpGaD
Trabectedin—SRC—Downstream signal transduction—RAF1—dilated cardiomyopathy	0.000604	0.00111	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR—RAF1—dilated cardiomyopathy	0.000601	0.00111	CbGpPWpGaD
Trabectedin—SRC—EGF/EGFR Signaling Pathway—RAF1—dilated cardiomyopathy	0.000601	0.00111	CbGpPWpGaD
Trabectedin—SRC—Signaling by ERBB2—RAF1—dilated cardiomyopathy	0.000598	0.0011	CbGpPWpGaD
Trabectedin—SRC—GAB1 signalosome—EGFR—dilated cardiomyopathy	0.000596	0.0011	CbGpPWpGaD
Trabectedin—SRC—ErbB1 downstream signaling—EGFR—dilated cardiomyopathy	0.000583	0.00107	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—RAC1—dilated cardiomyopathy	0.000575	0.00106	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR in disease—RAF1—dilated cardiomyopathy	0.00056	0.00103	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR—RAF1—dilated cardiomyopathy	0.000555	0.00102	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR in Cancer—RAF1—dilated cardiomyopathy	0.00055	0.00101	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000547	0.00101	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—RAF1—dilated cardiomyopathy	0.000547	0.00101	CbGpPWpGaD
Trabectedin—SRC—Focal Adhesion—RAF1—dilated cardiomyopathy	0.000529	0.000973	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	0.000527	0.000969	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—RAC1—dilated cardiomyopathy	0.00052	0.000957	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—TAZ—dilated cardiomyopathy	0.000515	0.000947	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—RAF1—dilated cardiomyopathy	0.000496	0.000912	CbGpPWpGaD
Trabectedin—SRC—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	0.000469	0.000862	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—SDHA—dilated cardiomyopathy	0.000465	0.000856	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—ITGB1—dilated cardiomyopathy	0.000462	0.00085	CbGpPWpGaD
Trabectedin—SRC—Signaling by SCF-KIT—EGFR—dilated cardiomyopathy	0.00046	0.000847	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—ITGB1—dilated cardiomyopathy	0.000453	0.000834	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—ANKRD1—dilated cardiomyopathy	0.000422	0.000777	CbGpPWpGaD
Trabectedin—SRC—Downstream signal transduction—EGFR—dilated cardiomyopathy	0.000414	0.000762	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR—EGFR—dilated cardiomyopathy	0.000412	0.000758	CbGpPWpGaD
Trabectedin—SRC—EGF/EGFR Signaling Pathway—EGFR—dilated cardiomyopathy	0.000412	0.000758	CbGpPWpGaD
Trabectedin—SRC—Signaling by ERBB2—EGFR—dilated cardiomyopathy	0.00041	0.000754	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—TAZ—dilated cardiomyopathy	0.000397	0.00073	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—CD36—dilated cardiomyopathy	0.000394	0.000725	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—ITGB1—dilated cardiomyopathy	0.000392	0.000721	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	0.000388	0.000715	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—CD36—dilated cardiomyopathy	0.000386	0.000711	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	0.000385	0.000708	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR in disease—EGFR—dilated cardiomyopathy	0.000384	0.000706	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—RAF1—dilated cardiomyopathy	0.000381	0.000701	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR—EGFR—dilated cardiomyopathy	0.00038	0.0007	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.00038	0.000699	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR in Cancer—EGFR—dilated cardiomyopathy	0.000377	0.000694	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—EGFR—dilated cardiomyopathy	0.000375	0.000691	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—RAC1—dilated cardiomyopathy	0.000371	0.000683	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.00037	0.000681	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	0.000365	0.000672	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—RAC1—dilated cardiomyopathy	0.000364	0.00067	CbGpPWpGaD
Trabectedin—SRC—Focal Adhesion—EGFR—dilated cardiomyopathy	0.000363	0.000667	CbGpPWpGaD
Trabectedin—SRC—Disease—NPPA—dilated cardiomyopathy	0.000362	0.000666	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	0.000362	0.000666	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	0.000361	0.000664	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—SDHA—dilated cardiomyopathy	0.000359	0.000661	CbGpPWpGaD
Trabectedin—SRC—Disease—PSEN2—dilated cardiomyopathy	0.000351	0.000645	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—CD36—dilated cardiomyopathy	0.000348	0.00064	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—RAF1—dilated cardiomyopathy	0.000345	0.000635	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	0.000344	0.000633	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—EGFR—dilated cardiomyopathy	0.00034	0.000625	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—CD36—dilated cardiomyopathy	0.000334	0.000615	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000333	0.000613	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	0.00033	0.000608	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—RAC1—dilated cardiomyopathy	0.000328	0.000603	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	0.000327	0.000602	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—RAC1—dilated cardiomyopathy	0.000315	0.000579	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—EGFR—dilated cardiomyopathy	0.000261	0.000481	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	0.000254	0.000467	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—RAF1—dilated cardiomyopathy	0.000246	0.000453	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000246	0.000452	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—RAF1—dilated cardiomyopathy	0.000241	0.000444	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	0.000239	0.000439	CbGpPWpGaD
Trabectedin—SRC—Immune System—ITGB1—dilated cardiomyopathy	0.000238	0.000437	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—EGFR—dilated cardiomyopathy	0.000237	0.000435	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000219	0.000403	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000218	0.000401	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000218	0.000401	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—RAF1—dilated cardiomyopathy	0.000217	0.0004	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	0.000216	0.000397	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000213	0.000392	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—RAF1—dilated cardiomyopathy	0.000209	0.000384	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000203	0.000373	CbGpPWpGaD
Trabectedin—SRC—Immune System—CD36—dilated cardiomyopathy	0.000203	0.000373	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.0002	0.000367	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000196	0.000361	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000194	0.000358	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000192	0.000353	CbGpPWpGaD
Trabectedin—SRC—Immune System—RAC1—dilated cardiomyopathy	0.000191	0.000351	CbGpPWpGaD
Trabectedin—SRC—Disease—RAC1—dilated cardiomyopathy	0.000176	0.000324	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000175	0.000322	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—GPX1—dilated cardiomyopathy	0.000169	0.000311	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—EGFR—dilated cardiomyopathy	0.000169	0.000311	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000168	0.000308	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—CD36—dilated cardiomyopathy	0.000165	0.000303	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—TNF—dilated cardiomyopathy	0.000161	0.000296	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000159	0.000293	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—EGFR—dilated cardiomyopathy	0.000149	0.000274	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—AGT—dilated cardiomyopathy	0.000148	0.000273	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—EGFR—dilated cardiomyopathy	0.000143	0.000263	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000137	0.000251	CbGpPWpGaD
Trabectedin—SRC—Immune System—RAF1—dilated cardiomyopathy	0.000127	0.000233	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—GPX1—dilated cardiomyopathy	0.000126	0.000233	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000123	0.000227	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—CD36—dilated cardiomyopathy	0.000123	0.000227	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—AGT—dilated cardiomyopathy	0.000118	0.000217	CbGpPWpGaD
Trabectedin—SRC—Disease—RAF1—dilated cardiomyopathy	0.000117	0.000215	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—AGT—dilated cardiomyopathy	0.000111	0.000204	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	9.75e-05	0.000179	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	9.5e-05	0.000175	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	8.97e-05	0.000165	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	8.89e-05	0.000164	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	8.74e-05	0.000161	CbGpPWpGaD
Trabectedin—SRC—Immune System—EGFR—dilated cardiomyopathy	8.68e-05	0.00016	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	8.66e-05	0.000159	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	8.55e-05	0.000157	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—RAF1—dilated cardiomyopathy	8.19e-05	0.000151	CbGpPWpGaD
Trabectedin—SRC—Disease—EGFR—dilated cardiomyopathy	8.02e-05	0.000148	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	7.87e-05	0.000145	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	7.8e-05	0.000143	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	5.86e-05	0.000108	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	5.71e-05	0.000105	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—EGFR—dilated cardiomyopathy	5.61e-05	0.000103	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	5.14e-05	9.46e-05	CbGpPWpGaD
